Nøkkelinformasjon info chevron_right

Viktig informasjon i saken hentes i sanntid direkte fra EPO sitt register (European Patent Register), slik at du enkelt og raskt får oversikt i saken.
Beskrivelse Verdi
Saken / databasen er sist oppdatert info  
Tittel AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS
Status
Hovedstatus
Detaljstatus 		I kraft info EP patent gjort gjeldende i Norge EP patent besluttet gjeldende i Norge (sjekk også detaljer i saken)
Patentnummer NO/EP3288940
Europeisk (EP) publiserings nummer EP3288940
EP levert
EP søknadsnummer 16723204.0
EP meddelt
Prioritet 2015.04.29, US 201562154313 P
Sakstype Europeisk
Løpedag
Utløpsdato
Allment tilgjengelig
Validert i Norge
Innehaver Rapport Therapeutics, Inc. (US)
Oppfinner BERRY, Cynthia G.B. (US) .... se mer/flere nedenfor
Fullmektig AWA NORWAY AS (NO)
Lenke til European patent Register Informasjon i saken, dokumenter og patentfamilie
Patentfamilie Se i Espacenet

Sammendrag og figur info chevron_right

EPO translation logo


Se forsidefigur og sammendrag i Espacenet

Beskrivelse og krav info chevron_right

T3

Beskrivelse

Krav

Patentkrav1. Forbindelse med formel (I):hvorX er N eller CR6;R1 er et medlem valgt fra gruppen bestående av: H, -C1-5-alkyl, -C1-5-halogenalkyl, -C1-5-alkoksy, -(CH2)2C(=O)OCH3, -(CH2)1-3OH, -(CH2)1-2O-C1-5-alkyl, -CH(CH3)OCH3, -C(CH3)2OCH3, -CH2SO2CH3, -C(=O)H, -NH-C1-5-alkyl, -N(C1-5-alkyl)2, -C(=O)N(H)C1-5-alkyl, -C(=O)N(C1-5-alkyl)2, -C3-8-cykloalkyl, -(CH2)-C3-8-cykloalkyl, -CH(CH3)-C3-8-cykloalkyl, -NH-C3-8-cykloalkyl, -C(=O)NH-cyklopropyl, -C(=O)-NH-fenyl, -C(=O)-azetidinyl, -C(=O)-pyrrolidinyl, azetidinyl, fenyl, benzyl, oksetanyl, tetrahydrofuranyl, tetrahydropyranyl, -CH2-pyrazinyl, furanyl, tienyl og pyridinyl, hvor -C3-8-cykloalkyl-, fenyl-, oksetanyl-, azetidinyl-, tetrahydrofuranyl-, tetrahydropyranyl-, pyridinyl-, pyrazinyl-, furanyl- og tienylringene hver uavhengig er valgfritt substituert med 1-3 substituenter valgt fra gruppen bestående av: halogen, -C1-5-alkyl, -C1-5-halogenalkyl, -C1-5-halogenalkoksy, -OH og -C(=O)OC1-5-alkyl;R2 er valgt fra gruppen bestående av:hvor hver R2 er uavhengig valgfritt substituert med et medlem valgt fra gruppen bestående av: 3H, halogen, -C1-5-alkyl, -C1-5-alkenyl, -CN, -OH, CH=CHCH2OH, -(CH2)3COH, C(=O)OC1-5-alkyl og fenyl;R3 er valgt fra gruppen bestående av: H, halogen, -C1-5-alkyl, -S-C1-5-alkyl, -C1-5-halogenalkyl, -C1-5-alkoksy, -NR3aR3b, -OH, -(CH2)1-3OH, -CH=CHCH2OH, -C3-8-cykloalkyl, piperidinyl, piperazinyl, morfolinyl og pyridyl;hver R3a og R3b er uavhengig valgt fra gruppen bestående av H og C1-5-alkyl;R4 er valgt fra gruppen bestående av: H, halogen, -CH3 og -CF3;R5 er valgt fra gruppen bestående av: H, -OH, -C1-5-alkyl, -C1-5-alkoksy, -C1-5-halogenalkyl, -C1-5-halogenalkoksy, -NR5aR5b, azetidinyl og morfolinyl;hver R5a og R5b er uavhengig valgt fra gruppen bestående av: -C1-5-alkyl og -C1-5-halogenalkyl;R6 er valgt fra gruppen bestående av: H, -OH, -CHF2 og -Br; ogR7 er H eller -C1-5-alkyl;og farmasøytisk akseptable salter, N-oksider eller solvater derav.2. Forbindelse ifølge krav 1, hvor R6 er H.3. Forbindelse ifølge krav 1, hvora) R1 er H, -C1-5-alkyl, -C1-5-halogenalkyl, -C1-5-alkoksy, -(CH2)2C(=O)-OCH3, -(CH2)3-OH, -C(CH3)2OCH3, -(CH2)1-2-O-C1-5-alkyl, -CH(CH3)-OCH3, -CH2SO2CH3, -NH-C1-5-alkyl, -N(C1-5-alkyl)2, -C(=O)N(H)C1-5-alkyl eller -C(=O)N(C1-5-alkyl)2; eller:b) R1 er H, -C1-5-alkyl, -C1-5-halogenalkyl, -C1-5-alkoksy, -(CH2)3-OH, -(CH2)1-2-O-C1-5-alkyl, -C(CH3)2OCH3 eller -CH(CH3)OCH3; eller:c) R1 er -C3-8-cykloalkyl, -(CH2)-C3-8-cykloalkyl, -CH(CH3)-C3-8-cykloalkyl, NH-C3-8-cykloalkyl, -C(=O)NH-cyklopropyl, -C(=O)-NH-fenyl, -C(=O)azetidinyl, -C(=O)-pyrrolidinyl, azetidinyl, fenyl, benzyl, oksetanyl, tetrahydrofuranyl, tetrahydropyranyl, -CH2-pyrazinyl, furanyl, tienyl eller pyridinyl, hvor -C3-8-cykloalkyl-, fenyl-, oksetanyl-, azetidinyl- og pyridinylringene hver uavhengig er valgfritt substituert med 1-3 substituenter uavhengig valgt fra gruppen bestående av: halogen, -C1-5-alkyl, -C1-5-halogenalkyl, -C1-5-halogenalkoksy, -OH og -C(=O)OC1-5-alkyl; eller:d) R1 er cyklopropyl, cyklobutyl, cyklopentyl, cykloheksyl, 1-fluorcyklopropyl, 3-fluorcyklobutyl, cyklopropanol, 2-furyl, 3-metyloksetan-3-yl, 2-tetrahydrofuran-3-yl, tetrahydropyran-4-yl, 2-tienyl, cyklopentylmetyl, pyrazin-2-ylmetyl, -C(=O)-NH-cyklopropyl, -C(=O)-NH-fenyl, -C(=O)-azetidinyl, -C(=O)-pyrrolidinyl eller NH-cykloheksyl;eller:e) R1 er -C3-8-cykloalkyl, fenyl, -CH2-fenyl eller pyridyl, hvor hvert fenyl, -CH2-fenyl eller pyridyl er valgfritt substituert med 1-3 substituenter uavhengig valgt fra gruppen bestående av: halogen, -C1-5-alkyl, -C1-5-halogenalkyl, -C1-5-halogenalkoksy og -OH; eller:f) R1 er fenyl, 2-klorfenyl, 4-fluorfenyl, 4-(difluormetyl)fenyl, 4-(trifluormetyl)fenyl, 4-(trifluormetoksy)fenyl, 4-fluor-3-metyl-fenyl, p-tolyl, mtolyl, pyridyl, 2-klor-4-pyridyl, 2-brom-4-pyridyl, 2-fluor-4-pyridyl, 2-[19F]fluor-4-pyridyl, 2-[18F]fluor-4-pyridyl, 5-fluor-2-pyridyl, 6-fluor-3-pyridyl eller pyridin-2-ol; eller:g) R1 er -C1-5-alkyl, -C1-5,halogenalkyl eller -C3-8-cykloalkyl, hvor -C3-8-cykloalkylet er valgfritt substituert med halogen.4. Forbindelse ifølge krav 1, hvor:a) R2 erhvor hver R2 er uavhengig valgfritt substituert med et medlem valgt fra gruppen bestående av: halogen, -C1-5-alkyl, -C1-5-alkenyl, -CN, -OH,CH=CHCH2OH, -(CH2)3COH, C(=O)C1-5-alkyl og fenyl; eller:b) R2 erhvor hver R2 er uavhengig valgfritt substituert med et medlem valgt fra gruppen bestående av: halogen, -C1-5-alkyl, -C1-5-alkenyl, -CN, -OH,CH=CHCH2OH, -(CH2)3COH, C(=O)OC1-5-alkyl og fenyl; ogR7 er H eller -CH3; eller:c) R2 erhvor hver R2 er uavhengig valgfritt substituert med et medlem valgt fra gruppen bestående av: halogen, -C1-5-alkyl, -C1-5-alkenyl, -CN, -OH, CH=CHCH2OH, -(CH2)3COH, C(=O)OC1-5-alkyl og fenyl; og R7 er H eller -CH3; eller:d) R2 er 1H-indazol-3-ol, 1H-indazol-5-yl, 1H-indazol-6-yl, 3-brom-1H-indazol-5-yl, 3-fluor-1H-indazol-5-yl, 1H-indazol-3-karbonitril, (E)-3-(1H-indazol-7-yl)-prop-2-en-1-ol, (1H-indazol-7-yl)propan-1-ol, 4-klor-1H-indazol-6-yl, 4-metyl-1H-indazol-6-yl, 7-brom-1H-indazol-5-yl, 7-fenyl-1H-indazol-5-yl, 7-propyl-1H-indazol-5-yl, 5-metyl 1H-indazol-7-karboksylat, tert-butyl-1H-indazol-1-karboksylat, 1H-indol-5-yl, 1H-pyrrolo[2,3-b]pyridin-5-yl eller 1H-pyrazolo-[3,4-b]pyridin-5-yl; eller: e) R2 er indolin-2-on, 7-metylindolin-2-on, 7-fluorindolin-2-on, 7-klorindolin-2-on, indolin-2,3-dion, 1,3-dihydropyrrolo[2,3-b]pyridin-2-on, 1,3-dihydrobenzimidazol-2-on, 3H-1,3-benzoksazol-2-on, 4-fluor-3H-1,3-benzoksazol-2-on, 4-brom-3H-1,3-benzoksazol-2-on, 3H-1,3-benzotiazol-2-on, 4-metyl-3H-1,3-benzotiazol-2-on, 3-metylbenzo[d]tiazol-2(3H)-on eller 4-klor-3H-1,3-benzotiazol-2-on; eller:f) R2 er 1H-indazol-3-ol, 1H-indazol-5-yl, 3-brom-1H-indazol-5-yl, 3-fluor-1H-indazol-5-yl, 1H-indazol-3-karbonitril, (E)-3-(1H-indazol-7-yl)prop-2-en-1-ol, (1H-indazol-7-yl)propan-1-ol, 7-brom-1H-indazol-5-yl, 7-fenyl-1H-indazol-5-yl, 7-propyl-1H-indazol-5-yl, 5-metyl 1H-indazol-7-karboksylat, tert-butyl-1H-indazol-1-karboksylat, indolin-2-on, 7-metylindolin-2-on, 7-fluorindolin-2-on, 7-klorindolin-2-on, 3H-1,3-benzotiazol-2-on, 4-metyl-3H-1,3-benzotiazol-2-on, 3-metylbenzo[d]tiazol-2(3H)-on eller 4-klor-3H-1,3-benzotiazol-2-on.5. Forbindelse ifølge krav 1, hvor R3 er H, halogen, -C1-5-alkyl, -C1-5-halogenalkyl, -OCH3, -NH2, -N(CH3)2 eller -OH.6. Forbindelse ifølge krav 1, hvor R4 er H, fluor eller -CH3.7. Forbindelse ifølge krav 1, hvor R5 er H, -OH, -C1-5-alkyl, -C1-5-halogenalkyl eller -C1-5-halogenalkoksy; fortrinnsvis hvor R5 er H.8. Forbindelse ifølge krav 1, hvor R6 er H.9. Forbindelse ifølge krav 1, hvor R7 er H.10. Forbindelse ifølge krav 1, hvor:a) X er N;R1 er H, C1-5-alkyl, C1-5-halogenalkyl, C1-5-alkoksy, fenyl eller C3-8-cykloalkyl, hvor C3-8-cykloalkylet og fenylet hver uavhengig er valgfritt substituert med 1-3 halogensubstituenter;R2 er R3 er H, C1-5-alkyl eller C1-5-halogenalkyl; eller:b) X er CR6, hvor R6 er H;R1 er H, C1-5-alkyl, C1-5-halogenalkyl, C1-5-alkoksy, fenyl eller C3-8-cykloalkyl, hvor C3-8-cykloalkylet og fenylet hver uavhengig er valgfritt substituert med 1-3 halogensubstituenter;R2 erhver R2 er uavhengig valgfritt substituert med halogen og -C1-5-alkyl;R3 er H, C1-5-alkyl eller C1-5-halogenalkyl; ogR4 er H.11. Forbindelse valgt fraa) gruppen bestående av:3-(1H-Indazol-5-yl)-2-fenyl-5-(trifluormetyl)-3H-imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-fenylimidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-5-metyl-2-fenylimidazo[4,5-b]pyridin; 2-(4-Fluorfenyl)-3-(1H-indazol-5-yl)-5-metylimidazo[4,5-b]pyridin;2-(4-Fluorfenyl)-3-(1H-indol-5-yl)-5-metoksyimidazo[4,5-b]pyridin;5-[2-(4-Fluorfenyl)-5-metoksyimidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-Klor-2-(4-fluorfenyl)-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin;2-(2-Klorfenyl)-3-(1H-indazol-5-yl)-5-metylimidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-6-metyl-2-fenylimidazo[4,5-b]pyridin;5-Klor-3-(1H-indazol-5-yl)-2-fenylimidazo[4,5-b]pyridin;5-Klor-2-cyklopentyl-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin;tert-Butyl-5-(5-metyl-2-fenylimidazo[4,5-b]pyridin-3-yl)indazol-1-karboksylat;3-(1H-Indol-5-yl)-2-fenyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;6-[2-Fenyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(5-Fluor-2-fenylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;6-[2-(4-Fluorfenyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(5-Metyl-2-fenylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;6-(5-Metoksy-2-fenylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;6-[2-tert-Butyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-(4-Fluorfenyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;5-[2-(4-Fluorfenyl)imidazo[4,5-b]pyridin-3-yl]-1,3-dihydrobenzimidazol-2-on; 2-(4-Fluorfenyl)-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin;5-[2-(4-Fluorfenyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;6-[2-(4-Fluorfenyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;6-(2-Fenylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;3-(1H-Indol-5-yl)-2-fenylimidazo[4,5-b]pyridin;6-[2-(4-Fluorfenyl)-5-metylimidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-(6-Fluor-3-pyridyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-(2-Fluor-4-pyridyl)-5-metylimidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[5-Klor-2-(4-fluorfenyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-(2-Fluor-4-pyridyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(5-Brom-2-fenylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;5-[2-(4-Fluorfenyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-(2-Fenylimidazo[4,5-b]pyridin-3-yl)indolin-2-on;5-[2-(4-Fluorfenyl)-5-metylimidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Fenyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[5-Fluor-2-(4-fluorfenyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on; 6-[2-Cyklopentyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-Cykloheksyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-Cyklopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-Tetrahydropyran-4-yl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;2-Cyklopropyl-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;6-[2-Etyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-Isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-Metyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;5-[2-Metyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Cykloheksyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Cyklobutyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Tetrahydropyran-4-yl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Isobutyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;(racemisk)-5-[2-Tetrahydrofuran-3-yl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[5-(Trifluormetyl)-2-(3,3,3-trifluorpropyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on; 5-[2-(Cyklopentylmetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Cyklopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Benzyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-(Pyrazin-2-ylmetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;2-Cyklopentyl-3-(1H-indol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-tert-Butyl-3-(1H-indol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-[2-Cyklopentyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-tert-Butyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;4-[2-(4-Fluorfenyl)-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin-7-yl]morfolin;5-[2-(4-Fluorfenyl)-7-morfolinimidazo[4,5-b]pyridin-3-yl]indolin-2-on;6-[2-Fenyl-5-(1-piperidyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(5-Morfolin-2-fenylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;6-[5-(Dimetylamino)-2-fenylimidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(5-(Difluormetyl)-2-fenyl-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]tiazol-2(3H)-on;6-[2-[4-(Difluormetyl)fenyl]imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[7-(Difluormetyl)-2-fenylimidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(7-Isopropyl-2-fenylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on; 6-(2-(4-Fluorfenyl)-5-(hydroksymetyl)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]-tiazol-2(3H)-on;6-(2-(4-Fluorfenyl)-7-hydroksy-5-metyl-3H-imidazo[4,5-b]pyridin-3-yl)benzo-[d]tiazol-2(3H)-on;5-(2-(3-Hydroksypropyl)-5-(trifluormetyl)-3H-imidazo[4,5-b]pyridin-3-yl)-indolin-2-on;5-(2-Cyklobutyl-5-metylimidazo[4,5-b]pyridin-3-yl)indolin-2-on;5-(2-Etyl-5-metylimidazo[4,5-b]pyridin-3-yl)indolin-2-on;5-[2-(3-Metyloksetan-3-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-(2-Metoksyetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;2-Cyklobutyl-5-cyklopropyl-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin;5-Cyklopropyl-3-(1H-indazol-5-yl)-2-isopropylimidazo[4,5-b]pyridin;6-[2-Cyklobutyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;Azetidin-1-yl-[3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-yl]-metanon;6-[5-Amino-2-(4-fluorfenyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;5-[2-(1-Etylpropyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-(2-Isopropyl-5-metylimidazo[4,5-b]pyridin-3-yl)indolin-2-on;3-(1H-Indazol-5-yl)-N-fenyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-karboksamid; 5-Cyklopropyl-2-(4-fluorfenyl)-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin;5-(2-Cyklopropyl-5-metylimidazo[4,5-b]pyridin-3-yl)indolin-2-on;5-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;3-(1H-Indazol-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;2-(Difluormetyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-(2-tienyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-(2-Furyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-[2-(1,1-Difluoretyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-(Difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-(5-Klor-2-cyklopropylimidazo[4,5-b]pyridin-3-yl)indolin-2-on;(racemisk)-5-[2-sec-Butyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-(2,2-Dimetylpropyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;3-(1H-Indazol-5-yl)-2-metyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-[2-Etyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;(racemisk)-3-(1H-Iindazol-5-yl)-2-tetrahydrofuran-3-yl-5-(trifluormetyl)-imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-isobutyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;(racemisk)-3-(1H-Indazol-5-yl)-2-sec-butyl-5-(trifluormetyl)imidazo[4,5-b]-pyridin; 2-Cyklobutyl-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-Cyklopentyl-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-Etyl-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-[2-Cyklopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-1,3-dihydrobenzimidazol-2-on;6-[2-Cyklopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;2-tert-Butyl-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-(4-Fluorfenyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;6-(5-Hydroksy-2-fenylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;2-(4-Fluorfenyl)-3-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-(2,2,2-trifluoretyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-Etoksy-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;1-[3-(1H-Indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-yl]-cyklopropanol;2-(1,1-Difluoretyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;(R/S)-2-(1-fluoretyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-tert-Butyl-2-(4-fluorfenyl)-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin;2-Cyklobutyl-3-(1H-indazol-5-yl)-5-isopropylimidazo[4,5-b]pyridin;2-(4-Fluorfenyl)-3-(1H-indazol-5-yl)-5-isopropylimidazo[4,5-b]pyridin; 2-(4-Fluor-3-metyl-fenyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;3-(1H-Indazol-5-yl)-2-(m-tolyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-(p-tolyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-(4-pyridyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-Cyklopropyl-3-(1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-N,N-dimetyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-karboksamid;3-(1H-Indazol-5-yl)-N-metyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-karboksamid;N-Cyklopropyl-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-karboksamid;3-(1H-Indazol-5-yl)-2-metoksy-5-(trifluormetyl)imidazo[4,5-b]pyridin;N-Etyl-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-amin;N-Cykloheksyl-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-amin;6-[2-Cyklobutyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(2-Cyklobutyl-5-metyl-7-morfolinimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;6-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(2-Cyklopropyl-7-metylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on; 6-(2-Cyklopropyl-5-metyl-7-morfolinimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;5-Klor-2-cyklobutyl-3-(1H-indazol-5-yl)-7-metylimidazo[4,5-b]pyridin;3-(7-Brom-1H-indazol-5-yl)-2-cyklobutyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-[5-Metyl-2-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Cyklopropyl-5-(difluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[5-(Difluormetyl)-2-isopropylimidazo[4,5-b]pyridin-3-yl]indolin-2-on;6-[5-Metyl-2-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-(2-Cyklopropyl-5-metylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;6-(2-Isopropyl-5-metylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;6-(2-Cyklobutyl-5-metylimidazo[4,5-b]pyridin-3-yl)-3H-1,3-benzotiazol-2-on;5-[2-(1,1-Difluoretyl)-5-metylimidazo[4,5-b]pyridin-3-yl]indolin-2-on;2-Cyklopropyl-3-(1H-indazol-5-yl)-5-metylimidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-isopropyl-5-metylimidazo[4,5-b]pyridin;2-Cyklobutyl-3-(1H-indazol-5-yl)-5-metylimidazo[4,5-b]pyridin;6-[2-(1,1-Difluoretyl)-5-metylimidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;3-(1H-Indazol-5-yl)-5-metyl-2-(trifluormetyl)imidazo[4,5-b]pyridin;2-(1,1-Difluoretyl)-3-(1H-indazol-5-yl)-5-metylimidazo[4,5-b]pyridin;5-[5-(Difluormetyl)-2-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on; 5-[2-(1,1-Difluoretyl)-5-(difluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;2-(4-Fluorfenyl)-3-(1H-indol-5-yl)-5-metylsulfanylimidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-fenylimidazo[4,5-b]pyridin-5-ol;2-Cyklopropyl-3-(1H-indazol-5-yl)-5-metoksyimidazo[4,5-b]pyridin;6-[2-Etyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;6-[2-Isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;6-[2-Tetrahydropyran-4-yl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;(R/S)-6-[2-Tetrahydrofuran-3-yl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;6-[2-(Etoksymetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;6-[2-tert-Butyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;5-[2-(2-Fluor-4-pyridyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;2-(2-Fluor-4-pyridyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-[2-(3-Fluorcyklobutyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;(R)-3-(1H-Indazol-5-yl)-2-sec-butyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;(S)-3-(1H-Indazol-5-yl)-2-sec-butyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-(5-Fluor-2-pyridyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin; 3-(1H-Indazol-5-yl)-5-isopropyl-2-(trifluormetyl)imidazo[4,5-b]pyridin;5-tert-Butyl-3-(1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-N-isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-karboksamid;[3-(1H-Indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-yl]-pyrrolidin-1-ylmetanon;2-(4-Fluorfenyl)-3-(1H-indol-5-yl)imidazo[4,5-b]pyridin;4-[2-(4-Fluorfenyl)-3-(1H-indol-5-yl)imidazo[4,5-b]pyridin-7-yl]morfolin;3-(1H-Indazol-5-yl)-2-[4-(trifluormetyl)fenyl]imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-2-[4-(trifluormetoksy)fenyl]imidazo[4,5-b]pyridin;5-[2-[4-(Trifluormetyl)fenyl]imidazo[4,5-b]pyridin-3-yl]indolin-2-on;tert-Butyl-3-[3-(2-oksoindolin-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-yl]-azetidin-1-karboksylat;5-[2-(Azetidin-3-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-(2,5-Dimetylimidazo[4,5-b]pyridin-3-yl)indolin-2-on;2-Cyklopentyl-3-(1H-indol-5-yl)-5-piperazin-1-ylimidazo[4,5-b]pyridin;Metyl-3-[3-(2-oksoindolin-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-yl]-propanoat;3-(7-Brom-1H-indazol-5-yl)-2-isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;6-(2-Cyklobutyl-5-(trifluormetyl)-3H-imidazo[4,5-b]pyridin-3-yl)-3-metylbenzo-[d]tiazol-2(3H)-on; 3-(7-3H-1H-indazol-5-yl)-2-isopropyl-5-(trifluormetyl)-3H-imidazo[4,5-b]-pyridin;3-(7-Brom-1H-indazol-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Fenyl-1H-indazol-5-yl)-2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin;2,5-bis(trifluormetyl)-3-(7-vinyl-1H-indazol-5-yl)-3H-imidazo[4,5-b]pyridin;6-(5-(Trifluormetyl)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]tiazol-2(3H)-on;3-(3-Fluor-1H-indazol-5-yl)-2-isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-Klor-3-(1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;5-Etyl-3-(1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-(4-Fluorfenyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;2-Etoksy-3-(3-fluor-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-Cyklopropyl-3-(3-fluor-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;2-Isopropyl-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-isopropylimidazo[4,5-b]pyridin;3-(1H-indazol-5-yl)-7-metyl-2-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-7-metyl-2-(trifluormetyl)imidazo[4,5-b]pyridin;7-Metyl-3-(7-metyl-1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin; 3-(1H-pyrazolo[3,4-b]pyridin-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Oksido-1H-pyrazolo[3,4-b]pyridin-7-ium-5-yl)-2,5-bis(trifluormetyl)-imidazo[4,5-b]pyridin;6-[5-(difluormetyl)-2-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;3-(7-Klor-1H-indazol-5-yl)-2,5-bis(difluormetyl)imidazo[4,5-b]pyridin;5-Cyklobutyl-3-(1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;5-(2-Etyl-5-metylimidazo[4,5-b]pyridin-3-yl)indolin-2,3-dion;5-(Difluormetyl)-3-(1H-indazol-5-yl)-2-isopropylimidazo[4,5-b]pyridin;5-(1,1-Difluoretyl)-3-(1H-indazol-5-yl)-2-isopropylimidazo[4,5-b]pyridin;2,5-bis(difluormetyl)-3-(7-metyl-1H-indazol-5-yl)imidazo[4,5-b]pyridin;2-(2-Fluor-4-pyridyl)-5-metyl-3-(7-metyl-1H-indazol-5-yl)imidazo[4,5-b]-pyridin;N-(2-Fluoretyl)-2-isopropyl-N-metyl-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-7-amin;5-[2-(2-Fluor-4-pyridyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2,3-dion;Metyl-3-[3-(2,3-dioksoindolin-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-yl]-propanoat;2-(2-Fluor-4-pyridyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-7-(2-fluoretoksy)-2,5-bis(trifluormetyl)imidazo-[4,5-b]pyridin; (E)-3-(5-(2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin-3-yl)-1H-indazol-7-yl)prop-2-en-1-ol;3-(5-(2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin-3-yl)-1H-indazol-7-yl)-propan-1-ol;3-(7-Propyl-1H-indazol-5-yl)-2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin;(E)-3-(3-(7-Metyl-1H-indazol-5-yl)-2-(trifluormetyl)-3H-imidazo[4,5-b]pyridin-5-yl)prop-2-en-1-ol;3-(3-(7-Metyl-1H-indazol-5-yl)-2-(trifluormetyl)-3H-imidazo[4,5-b]pyridin-5-yl)-propan-1-ol;3-(7-Metyl-1H-indazol-5-yl)-5-propyl-2-(trifluormetyl)-3H-imidazo[4,5-b]-pyridin;4-[3-(1H-Indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-yl]pyridin-2-ol;3-(1H-Indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-cyklopropyl-5-(difluormetyl)imidazo[4,5-b]pyridin;5-(Difluormetyl)-2-(4-fluorfenyl)-3-(7-metyl-1H-indazol-5-yl)imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-5-(difluormetyl)-2-(4-fluorfenyl)imidazo[4,5-b]-pyridin;6-[7-Morfolin-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;4-[3-(1H-Indazol-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-7-yl]-morfolin;2-(1,1-Difluorpropyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin; 6-[2-(1,1,2,2,2-Pentafluoretyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-(Difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-(Difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;6-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzoksazol-2-on;3-(3-Fluor-1H-indazol-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;5-(Difluormetyl)-3-(1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;6-[2-Metoksy-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;6-[2-Etoksy-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;2-Metoksy-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-Etoksy-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;5-[2-Etoksy-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Metoksy-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;3-(1H-indazol-5-yl)-2-(metylsulfonylmetyl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;2-(3-Fluorcyklobutyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;2-(3-Fluorcyklobutyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin; 3-(7-Klor-1H-indazol-5-yl)-2-(3-fluorcyklobutyl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(3-fluorcyklobutyl)-5-metylimidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(3-fluorcyklobutyl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;2-(1-Metoksy-1-metyl-etyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)-imidazo[4,5-b]pyridin;2-(1,1-Difluoretyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;2-(1-Fluor-1-metyl-etyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(1-fluor-1-metyl-etyl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;2-Cyklopropyl-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;(*R)-2-(1-Fluoretyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;(*S)-2-(1-Fluoretyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(1-fluorcyklopropyl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;2-(1-Fluorcyklopropyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;3-(1H-Indazol-5-yl)-N-isopropyl-N-metyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-2-karboksamid; 2-(2-Klor-4-pyridyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;2-(2-Brom-4-pyridyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;5-(Difluormetyl)-2-(2-fluor-4-pyridyl)-3-(7-metyl-1H-indazol-5-yl)imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-5-(difluormetyl)-2-(2-fluor-4-pyridyl)imidazo[4,5-b]-pyridin;3-(4-Klor-1H-indazol-6-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;6-[2-(1,1-Difluoretyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on;3-(7-Klor-1H-indazol-5-yl)-2-(1,1-difluoretyl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-5-metyl-2-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-5-(difluormetyl)-2-isopropylimidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;5-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-7-klor-indolin-2-on;7-Klor-5-[2-(difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-(Difluormetyl)-2-isopropyl-3-(7-metyl-1H-indazol-5-yl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-5-(difluormetyl)-2-metylimidazo[4,5-b]pyridin;5-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-7-metylindolin-2-on; 5-[2-(1,1-Difluoretyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-7-metylindolin-2-on;3-(7-Klor-1H-indazol-5-yl)-2-(difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(difluormetyl)-5-metylimidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-6-fluor-2-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Brom-1H-indazol-5-yl)-2-(difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;6-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-4-metyl-3H-1,3-benzotiazol-2-on;6-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-4-klor-3H-1,3-benzotiazol-2-on;6-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-4-fluor-3H-1,3-benzoksazol-2-on;Metyl-5-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-1H-indazol-7-karboksylat;Metyl-5-[2-(difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-1H-indazol-7-karboksylat;2-(Difluormetyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;5-[2-(Difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-7-metylindolin-2-on;5-[2-(Difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-7-fluorindolin-2-on;3-(4-Metyl-1H-indazol-6-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin; 6-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-4-brom-3H-1,3-benzoksazo1-2-on;3-(1H-Indazol-6-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;5-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-1,3-dihydropyrrolo[2,3-b]-pyridin-2-on;3-(1H-Pyrrolo[2,3-b]pyridin-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Metyl-1H-indazol-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin;5-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-1H-indazol-3-karbonitril;5-[2-(Difluormetyl)-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-1H-indazol-3-ol;6-[2-Cyklopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;3-(3-Brom-1H-indazol-5-yl)-2-isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;7-Klor-5-[2-isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;3-(7-Klor-1H-indazol-5-yl)-6-fluor-2-isopropylimidazo[4,5-b]pyridin;5-[2-Isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-1,3-dihydropyrrolo-[2,3-b]pyridin-2-on;2-Isopropyl-3-(1H-pyrazolo[3,4-b]pyridin-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;2-Isopropyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin;3-(7-Allyl-1H-indazol-5-yl)-2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin;3-(7-(Prop-1-en-2-yl)-1H-indazol-5-yl)-2,5-bis(trifluormetyl)-3H-imidazo-[4,5-b]pyridin; 3-(7-Klor-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-cyklopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-cyklobutyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;7-Metyl-5-[2-metyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;5-[2-Isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-7-metylindolin-2-on;2-Isopropyl-3-(4-metyl-1H-indazol-6-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-metyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;7-Klor-5-[2-metyl-5-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;3-(7-Klor-1H-indazol-5-yl)-2-etyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;2-Etyl-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(7-Metyl-1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;7-Metyl-5-[2-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on;2-Metyl-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]pyridin;3-(1H-Indazol-5-yl)-5-(2-pyridyl)-2-(trifluormetyl)imidazo[4,5-b]pyridin;2-Cyklopropyl-5-(difluormetyl)-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin;5-(Difluormetyl)-2-(4-fluorfenyl)-3-(1H-indazol-5-yl)imidazo[4,5-b]pyridin;5-(Difluormetyl)-3-(1H-indazol-5-yl)-2-fenylimidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-5-(difluormetyl)-2-(trifluormetyl)imidazo[4,5-b]-pyridin; 5-[5-(Difluormetyl)-2-(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-7-fluorindolin-2-on;5-(Difluormetyl)-3-(7-metyl-1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(2-fluor-4-pyridyl)-5-metylimidazo[4,5-b]pyridin;3-(7-Brom-1H-indazol-5-yl)-2-(2-fluor-4-pyridyl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;5-(2-(Hydroksymetyl)-6-(trifluormetyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on;(1-(1H-Indazol-5-yl)-6-(trifluormetyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)metanol;7-Metyl-5-(2-metyl-6-(trifluormetyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;5-(2-Isopropyl-1H-pyrrolo[2,3-b]pyridin-1-yl)-7-metyl-1H-indazol;1-(7-Klor-1H-indazol-5-yl)-2-metylpyrrolo[2,3-b]pyridin;5-[6-(Difluormetyl)-2-isopropylpyrrolo[2,3-b]pyridin-1-yl]-7-metylindolin-2-on;1-(1H-Indazol-5-yl)-2-isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;5-[2-(Difluormetyl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-7-metylindolin-2-on;6-[2-(Difluormetyl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-3H-1,3-benzotiazol-2-on;7-Klor-5-(2-metylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;1-(7-Metyl-1H-indazol-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-3-ol;3-(Difluormetyl)-1-(7-metyl-1H-indazol-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]-pyridin; 6-Metyl-1-(7-metyl-1H-indazol-5-yl)pyrrolo[2,3-b]pyridin;5-(2-Isopropyl-6-metylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;2-(4-Fluorfenyl)-1-(1H-indol-5-yl)-6-metoksy-pyrrolo[2,3-b]pyridin;2-(4-Fluorfenyl)-1-indolin-5-ylpyrrolo[2,3-b]pyridin;2-(4-Fluorfenyl)-1-(1H-indol-5-yl)pyrrolo[2,3-b]pyridin;5-[3-Brom-2-(4-fluorfenyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-[2-(4-Fluorfenyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;6-Fluor-2-(4-fluorfenyl)-1-(1H-indol-5-yl)pyrrolo[2,3-b]pyridin;5-[3-Brom-6-fluor-2-(4-fluorfenyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-[6-Fluor-2-(4-fluorfenyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;1-(1H-Indol-5-yl)-2-metyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;5-[2-Metyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;7-Metyl-5-(2-metyl-1H-pyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;5-(2-Metyl-6-(trifluormetyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)-1H-indazol;6-(2-Metyl-6-(trifluormetyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)benzo[d]tiazol-2(3H)-on;1-(7-Klor-1H-indazol-5-yl)-2-isopropylpyrrolo[2,3-b]pyridin;7-Klor-5-(2-isopropylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;5-(2-Isopropylpyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on;5-(2-Cyklopropylpyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on; 5-(2-Isopropyl-6-metylpyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on;7-Fluor-5-(2-isopropylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;7-Fluor-5-(2-isopropyl-6-metylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;7-Fluor-5-(2-metylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;7-Fluor-5-[2-metyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;(RS)-7-Fluor-5-[2-tetrahydrofuran-3-yl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;7-Fluor-5-[2-(metoksymetyl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-[2-Isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-7-metylindolin-2-on;(RS)-5-[2-(1-Metoksyetyl)pyrrolo[2,3-b]pyridin-1-yl]-7-metylindolin-2-on;7-Fluor-5-[2-isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;2-Isopropyl-1-(7-metyl-1H-indazol-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;2-(3-Fluorpropyl)-1-(7-metyl-1H-indazol-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]-pyridin;1-(7-Klor-1H-indazol-5-yl)-2-(3-fluorpropyl)-6-(trifluormetyl)pyrrolo[2,3-b]-pyridin;2-Metyl-1-(7-metyl-1H-indazol-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;1-(7-Klor-1H-indazol-5-yl)-2-metyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;2-Metyl-1-(7-metyl-1H-indazol-5-yl)pyrrolo[2,3-b]pyridin;5-[2-Isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-1H-pyrazolo[3,4-b]-pyridin; 1-(7-Metyl-1H-indazol-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;7-Metyl-5-(6-metylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;7-Fluor-5-(6-metylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;5-(2-Cyklopropyl-6-metylpyrrolo[2,3-b]pyridin-1-yl)indolin-2-on;2-(4-Fluorfenyl)-1-(1H-indol-5-yl)-6-metylpyrrolo[2,3-b]pyridin;5-[2-(4-Fluorfenyl)-6-metylpyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-[6-Klor-2-(4-fluorfenyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-[2-(4-Fluorfenyl)-6-metoksypyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;6-Klor-2-(4-fluorfenyl)-1-(1H-indol-5-yl)pyrrolo[2,3-b]pyridin;6-tert-Butoksy-2-(4-fluorfenyl)-1-(1H-indol-5-yl)pyrrolo[2,3-b]pyridin;2-(4-Fluorfenyl)-1-(1H-indol-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;1-(1H-Indol-5-yl)-2-fenyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;5-[3-Brom-2-cyklopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;6-Metyl-2-fenyl-1-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,3-b]pyridin;2-Isopropyl-1-(1H-pyrrolo[2,3-b]pyridin-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]-pyridin;2-Metyl-1-(1H-pyrrolo[2,3-b]pyridin-5-yl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin;5-(3-Brom-6-metyl-2-fenylpyrrolo[2,3-b]pyridin-1-yl)-1,3-dihydropyrrolo-[2,3-b]pyridin-2-on; 5-[3-Brom-2-isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-1,3-dihydropyrrolo[2,3-b]pyridin-2-on;5-[3-Brom-2-metyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-1,3-dihydropyrrolo[2,3-b]pyridin-2-on;5-[2-Isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-[2-Fenyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-[2-(4-Fluorfenyl)-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-[2-Cyklopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on;5-(6-Metyl-2-fenylpyrrolo[2,3-b]pyridin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridin-2-on;5-[2-Isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-1,3-dihydropyrrolo-[2,3-b]pyridin-2-on;5-[2-Metyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-1,3-dihydropyrrolo-[2,3-b]pyridin-2-on;5-(2-Etylpyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on;(*R)-2-(sec-Butyl)-3-(7-klor-1H-indazol-5-yl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;(*S)-2-(sec-Butyl)-3-(7-klor-1H-indazol-5-yl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;(*R)-2-(sec-Butyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;(*S)-2-(sec-Butyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin; (*R)-3-(7-Klor-1H-indazol-5-yl)-2-(1-fluoretyl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;(*S)-3-(7-Klor-1H-indazol-5-yl)-2-(1-fluoretyl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(1,1-difluoretyl)-5-metyl-3H-imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(cyklopropylmetyl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-propyl-5-(trifluormetyl)-3H-imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(metoksymetyl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-isobutyl-5-(trifluormetyl)-3H-imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-5-metoksy-2-(trifluormetyl)-3H-imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(2,2,2-trifluoretyl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;2-(1,1-Difluorpropyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;3-(7-Metyl-1H-indazol-5-yl)-5-(trifluormetyl)-2-(3,3,3-trifluorpropyl)-3H-imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2,6-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin;5-(5-Fluor-2-isopropyl-1H-pyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on;5-(6-(Difluormetyl)-2-metyl-1H-pyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on; 1-(7-Metyl-2-oksoindolin-5-yl)-6-(trifluormetyl)-1H-pyrrolo[2,3-b]pyridin-2-karbaldehyd;2-(2-Klor-4-pyridyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;2-(2-Brom-4-pyridyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;2-(2-19Fluor-4-pyridyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;2-(2-[18F]fluor-4-pyridyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin;og farmasøytisk akseptable salter derav; eller:b) gruppen bestående av:3-(7-Etyl-1H-indazol-5-yl)-2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin;3-(7-Isopropyl-1H-indazol-5-yl)-2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin;5-(2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]pyridin-3-yl)-1H-indazol-7-karbonitril;3-(7-Klor-1H-indazol-5-yl)-2-isopropyl-6-(trifluormetyl)-3H-imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-6-metyl-2-(trifluormetyl)-3H-imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-7-metyl-2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]-pyridin;7-Metyl-3-(7-metyl-1H-indazol-5-yl)-2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]-pyridin; 3-(7-Klor-1H-indazol-5-yl)-2-isopropyl-7-metyl-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-7-metoksy-2,5-bis(trifluormetyl)-3H-imidazo[4,5-b]-pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(1-cyklopropyletyl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(1-metylcyklopropyl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;3-(7-Metyl-1H-indazol-5-yl)-2-(1-metylcyklopropyl)-5-(trifluormetyl)-3H-imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-2-(1-metoksyetyl)-5-(trifluormetyl)-3H-imidazo-[4,5-b]pyridin;6-Klor-3-(7-klor-1H-indazol-5-yl)-2-(trifluormetyl)-3H-imidazo[4,5-b]pyridin;3-(7-Klor-1H-indazol-5-yl)-5-(trifluormetyl)-2-(1,1,1-trifluorpropan-2-yl)-3H-imidazo[4,5-b]pyridin;5-(4-(Dimetylamino)-2-metyl-1H-pyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on;5-(4-(Azetidin-1-yl)-2-metyl-1H-pyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on;5-(4-Metoksy-2-metyl-1H-pyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on; og5-(2,4-Dimetyl-1H-pyrrolo[2,3-b]pyridin-1-yl)-7-metylindolin-2-on;og farmasøytisk akseptable salter, N-oksider eller solvater derav.12. Forbindelse ifølge krav 11, hvor forbindelsen er: a) 5-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]indolin-2-on, og farmasøytisk akseptable salter, N-oksider eller solvater derav; eller:b) 2-(Difluormetyl)-3-(1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin, og farmasøytisk akseptable salter, N-oksider eller solvater derav; eller:c) 3-(1H-Indazol-5-yl)-2-isopropyl-5-(trifluormetyl)imidazo[4,5-b]pyridin, og farmasøytisk akseptable salter, N-oksider eller solvater derav; eller:d) 6-[2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin-3-yl]-3H-1,3-benzotiazol-2-on, og farmasøytisk akseptable salter, N-oksider eller solvater derav eller:e) 2-Isopropyl-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo[4,5-b]-pyridin, og farmasøytisk akseptable salter, N-oksider eller solvater derav; eller:f) 2-(Difluormetyl)-3-(7-metyl-1H-indazol-5-yl)-5-(trifluormetyl)imidazo-[4,5-b]pyridin, og farmasøytisk akseptable salter, N-oksider eller solvater derav; eller:g) 3-(7-Metyl-1H-indazol-5-yl)-2,5-bis(trifluormetyl)imidazo[4,5-b]pyridin, og farmasøytisk akseptable salter, N-oksider eller solvater derav; eller:h) 7-Fluor-5-[2-isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]indolin-2-on, og farmasøytisk akseptable salter, N-oksider eller solvater derav; eller:i) 5-(Difluormetyl)-3-(1H-indazol-5-yl)-2-(trifluormetyl)imidazo[4,5-b]-pyridin, og farmasøytisk akseptable salter, N-oksider eller solvater derav; eller:j) 5-[2-Isopropyl-6-(trifluormetyl)pyrrolo[2,3-b]pyridin-1-yl]-7-metylindolin-2-on, og farmasøytisk akseptable salter, N-oksider eller solvater derav.13. Farmasøytisk sammensetning omfattende:(A) en virksom mengde av minst én forbindelse ifølge krav 1; eller et farmasøytisk akseptabelt salt, N-oksid eller solvat derav; og(B) minst én farmasøytisk akseptabel eksipiens. 14. Farmasøytisk sammensetning omfattende en virksom mengde av minst én forbindelse ifølge krav 12 i) eller 12 j) og minst én farmasøytisk akseptabel eksipiens.15. Forbindelse ifølge krav 1; eller et farmasøytisk akseptabelt salt, N-oksid eller solvat derav av forbindelser med formel (I), for anvendelse ved behandling av et individ som lider av eller er blitt diagnostisert med en sykdom, forstyrrelse eller medisinsk tilstand som medieres av AMPA-receptoraktivitet, hvilken behandling omfatter å administrere en virksom mengde av forbindelsen med formel (I) til et individ som har behov for slik behandling; hvor:a) den AMPA-receptormedierte sykdom, forstyrrelse eller medisinske tilstand er valgt fra cerebral iskjemi, hodeskade, ryggradskade, Alzheimers sykdom, Parkinsons sykdom, amyotrofisk lateral sklerose (ALS), Huntingtons korea, AIDS nerveforstyrrelse, epilepsi, mental forstyrrelse, mobilitetsforstyrrelse, smerte, spastisitet, nerveforstyrrelse av toksin i mat, forskjellige neurodegenerative sykdommer, forskjellige mentale sykdommer, kronisk smerte, migrene, kreftsmerter, diabetisk neuropati, encefalitt, akutt spredt encefalogenmyelitt, akutt demyelinerende polyneuropati (Guillain Barre-syndrom), kronisk inflammatorisk demyelinerende polyneuropati, multippel sklerose, Marchifava-Bignami-sykdom, sentral pontin myelinolyse, Devic-syndrom, Balo-sykdom, HIV- eller HTLV-myelopati, progressiv multifokal leucoencefalogenpati, en sekundær demyelinerende forstyrrelse (for eksempel CNS-lupus erythematoder, polyarteritt nodosa, Sjogren-syndrom, sarkoidose og isolert cerebral vaskulitt), schizofreni, prodromal schizofreni, kognitiv forstyrrelse, depresjon, angstforstyrrelser, engstelig depresjon og bipolar forstyrrelse; eller:b) den AMPA-receptormedierte sykdom, forstyrrelse eller tilstand er depresjon, post-traumatisk stressforstyrrelse, epilepsi, schizofreni, prodromal schizofreni eller en kognitiv forstyrrelse.
Hva betyr A1, B, B1, C osv? info

Klasser info chevron_right

Innehaver(e) info chevron_right

Innehaver i Norge:
Rapport Therapeutics, Inc.
201 Brookline Ave. Suite 1401 MA02215 BOSTON US
Innehaver i EP:
Janssen Pharmaceutica NV
Turnhoutseweg 30 2340 Beerse BE
Patentstyrets saksnr. 2025/07248
Din referanse: 175892-HAIN   Levert  
Gjeldende status Avgjort

Avsender

AWA NORWAY AS
Postboks 1052 Hoff 0218 OSLO NO ( OSLO kommune, Oslo fylke )

Org.nummer: 925400262

Statushistorie for 2025/07248

Liste over statusendringer i sakshistorikk
Hovedstatus Beslutningsdato, detaljstatus
Avgjort Forespørsel tatt til følge
Under behandling Mottatt

Korrespondanse for 2025/07248

expand_more
Liste over sakshistorikk og korrespondanse
Dato Type korrespondanse Journal beskrivelse
Utgående GH Forespørsel
02-01 Via Altinn-sending GH Forespørsel
Innkommende, AR684442732 Generell henvendelse
01-01 Generell henvendelse Generell henvendelse
01-02 Fullmakt 175892 Fullmakt_Rapport Therapeutics, Inc.
Informasjon om ikke tilgjengelige dokumenter

Oppfinner(e) info chevron_right

BERRY, Cynthia G.B.
3210 Merryfield Row San Diego, California 92121 US
CHEN, Gang
3210 Merryfield Row San Diego, California 92121 US
JOURDAN, Fabrice Loic
Calle Cisne 27Los Altos de Olias E-45280 Olias del Rey ES
LEBOLD, Terry Patrick
3210 Merryfield Row San Diego, California 92121 US
LIN, David Wei
3210 Merryfield Row San Diego, California 92121 US
PENA PIÑÓN, Miguel Angel
C/ Río Jarama 75A E-45007 Toledo ES
RAVULA, Suchitra
3210 Merryfield Row San Diego, California 92121 US
SAVALL, Bradley M.
3210 Merryfield Row San Diego, California 92121 US
SWANSON, Devin M.
3210 Merryfield Row San Diego, California 92121 US
WU, Dongpei
3210 Merryfield Row San Diego, California 92121 US
ZHANG, Wei
3210 Merryfield Row San Diego, California 92121 US
AMERIKS, Michael K.
3210 Merryfield Row San Diego, California 92121 US

Fullmektig info chevron_right

Fullmektig i Norge:
AWA NORWAY AS
Postboks 1052 Hoff 0218 OSLO NO ( OSLO kommune, Oslo fylke )

Org.nummer: 925400262
Din referanse: 175892-TG/HGI
  • Foretaksnavn:
  • Foretaksform:
  • Næring:
  • Forretningsadresse:
     

Kilde: Brønnøysundregistrene
Fullmektig i EP:
Carpmaels & Ransford LLP
One Southampton Row London WC1B 5HA GB

Prioritet info chevron_right

2015.04.29, US 201562154313 P

Anførte dokumenter info chevron_right

MACOR J E ET AL: "The discovery of a novel and potent benzodiazepine receptor pharmacophore", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 5, no. 20, 19 October 1995 (1995-10-19), pages 2397-2402, XP004135272, ISSN: 0960-894X, DOI: 10.1016/0960-894X(95)00418-S (B1)

WO-A2-00/01376 (B1)

WO-A2-2011/156245 (B1)

WO-A2-2010/005528 (B1)

WO-A2-2007/135529 (B1)

Sakshistorikk info chevron_right

Statushistorie

Liste over statusendringer i sakshistorikk
Hovedstatus Beslutningsdato, detaljstatus
EP patent gjort gjeldende i Norge EP patent besluttet gjeldende i Norge
EP under behandling Forespørsel om å gjøre EP patent gyldig er mottatt

Korrespondanse

expand_more file_download  
Liste over sakshistorikk og korrespondanse
Dato Type korrespondanse Journal beskrivelse
Innkommende EP Publiseringsdokument fra EPO
09-01 EP Publiseringsdokument fra EPO EP Publiseringsdokument fra EPO
Innkommende EP Publiseringsdokument fra EPO
08-01 EP Publiseringsdokument fra EPO EP Publiseringsdokument fra EPO
Innkommende EP Publiseringsdokument fra EPO
07-01 EP Publiseringsdokument fra EPO EP Publiseringsdokument fra EPO
Innkommende EP Publiseringsdokument fra EPO
06-01 EP Publiseringsdokument fra EPO EP Publiseringsdokument fra EPO
Innkommende EP Publiseringsdokument fra EPO
05-01 EP Publiseringsdokument fra EPO EP Publiseringsdokument fra EPO
Innkommende EP Publiseringsdokument fra EPO
04-01 EP Publiseringsdokument fra EPO EP Publiseringsdokument fra EPO
Utgående EP Registreringsbrev (3210) (PTEP3288940)
03-01 Brev UT EP Registreringsbrev (3210) (PTEP3288940)
Innkommende, AR426387540 Søknadsskjema Patent
01-01 Søknadsskjema Patent Søknadsskjema Patent
01-02 Patenttegninger 175892 Generalfullmakt
01-03 Patenttegninger 175892 Krav NO
Innkommende EP Publiseringsdokument fra EPO
02-01 EP Publiseringsdokument fra EPO EP Publiseringsdokument fra EPO
Informasjon om ikke tilgjengelige dokumenter

Betaling info chevron_right

Til betaling:

Neste fornyelse/årsavgift:

Betalingshistorikk:

Liste av betalinger
Beskrivelse / Fakturanummer Betalingsdato Beløp Betaler Status
Årsavgift 10. avg. år (EP) 2025.04.29 4160 COMPUTER PACKAGES INC. Betalt og godkjent
Årsavgift 9. avg. år (EP) 2024.04.29 3710 COMPUTER PACKAGES INC. Betalt og godkjent
Årsavgift 8. avg. år (EP) 2023.04.27 2550 COMPUTER PACKAGES INC. Betalt og godkjent
Årsavgift 7. avg. år (EP) 2022.04.11 2200 CPA GLOBAL LIMITED Betalt og godkjent
32106291 expand_more 2021.05.25 5500 OSLO PATENTKONTOR AS Betalt
Årsavgift 6. avg. år (EP) 2021.04.09 2000 CPA GLOBAL LIMITED Betalt og godkjent
Denne oversikten kan mangle informasjon, spesielt for eldre saker, om tilbakebetaling, internasjonale varemerker og internasjonale design.

Publikasjon(er) info chevron_right

Lenker til publikasjoner og Norsk Patenttidende (søkbare tekstdokumenter)

Oversettelse av europeisk patentskrift
Allment tilgjengelig patentsøknad
Norsk Patenttidende - ved meddelelse
Nye digitale Norske Tidende, nyhet om tjenesten ved lansering
Om Norske Tidende
Hva betyr A1, B, B1, C osv? info
Kapitler uten data er fjernet. Melding opprettet: 13.06.2025 21:29:26